Physician Assistant · Brooklyn, NY
NPI
1114166980
Since 2009
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4620 3rd Ave, Sunset Medical PC
Brooklyn, NY, 11220
Phone (718) 492-4109
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
1,141 services
Medicare patients, 2024
68
Average age 75
Drug cost, 2024
$2.9M
12,891 prescriptions
Company payments, 2025
$4,670
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Claudia M Pineda-Muyir was code 99213 (office e&m - established), 206 times for 55 patients. In total Claudia M Pineda-Muyir billed 1,141 services in 52 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 206 | 55 | $62.51 | $13K |
| 36415 Venipuncture Blood Collection | Office | 108 | 58 | $8.65 | $934 |
| 96372 Injection Administration | Office | 104 | 31 | $10.00 | $1,040 |
| 99214 Office E&M - Established | Office | 86 | 43 | $88.88 | $7,643 |
| 99212 Office E&M - Established | Office | 52 | 35 | $36.85 | $1,916 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 45 | 20 | $0.15 | $6.61 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 42 | 19 | $0.22 | $9.32 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 37 | 33 | $24.09 | $891 |
| 96366 Intravenous Infusion, Hydration | Office | 33 | 15 | $14.86 | $490 |
| 99406 Behavioral Health Services | Office | 33 | 33 | $14.05 | $464 |
| 96365 Intravenous Infusion, Hydration | Office | 33 | 15 | $48.34 | $1,595 |
| 99497 Care Management/Coordination | Office | 31 | 31 | $44.11 | $1,367 |
| 99484 Behavioral Health Services | Office | 29 | 26 | $36.70 | $1,064 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 21 | 21 | $125.38 | $2,633 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 21 | 21 | $18.46 | $388 |
By year: 2022 $64K for 2,215 services; 2023 $48K for 1,495 services; 2024 $39K for 1,141 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 108 | 58 | $8.65 | $934 |
Medicare prescription drug claims, 2024
In 2024, the drug Claudia M Pineda-Muyir prescribed most often to Medicare patients was Montelukast Sodium, with 502 prescriptions and refills. In total Claudia M Pineda-Muyir wrote 12,891 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 502 | 874 | 143 | $4,847 |
| Rosuvastatin Calcium Generic | 495 | 1,384 | 180 | $6,625 |
| Fluticasone Propionate Generic | 349 | 417 | 122 | $2,298 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 309 | 368 | 94 | $10K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 308 | 769 | 107 | $610 |
| Famotidine Generic | 286 | 436 | 90 | $9,922 |
| Amlodipine Besylate Generic | 285 | 774 | 89 | $1,645 |
| Farxiga Dapagliflozin Propanediol | 260 | 414 | 55 | $225K |
| Kerendia Finerenone | 251 | 438 | 49 | $269K |
| Metoprolol Succinate Generic | 249 | 653 | 78 | $3,982 |
| Gabapentin Generic | 212 | 482 | 66 | $1,987 |
| Vascepa Icosapent Ethyl | 210 | 475 | 72 | $91K |
| Atorvastatin Calcium Generic | 197 | 509 | 60 | $2,045 |
| Jardiance Empagliflozin | 196 | 364 | 55 | $205K |
| Clobetasol Propionate Generic | 186 | 188 | 42 | $25K |
Brand drugs: 3,453 claims; generic drugs: 9,223 claims; opioid claims: 155.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Claudia M Pineda-Muyir $4,670 ($4,670 in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $671.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 27 | $671 |
| Forte Bio-Pharma LLC | 15 | $585 |
| Pfizer Inc. PFE | 24 | $579 |
| Axsome Therapeutics, Inc. AXSM | 19 | $445 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 13 | $353 |
| Novo Nordisk Inc NVO | 7 | $349 |
| Galderma Laboratories, L.P. GALD.SW | 6 | $224 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $201 |
| Abbvie Inc. ABBV | 10 | $181 |
| Amgen Inc. AMGN | 9 | $155 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.